Article
p27kip1: a target for tumor therapies?
9 May 2007
Abstract excerpt
The cyclin kinase inhibitor p27kip1 acts as a potent tumor supressor protein in a variety of human cancers. Its expression levels correlate closely with the overall prognosis of the affected patient and often predict the outcome to different treatment modalities. In contrast to other tumor suppressor proteins p27 expression levels in tumor cells are frequently regulated by ubiquitin dependent proteolysis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
